Literature DB >> 1335657

Genetic, antigenic and biological differences between strains of hepatitis A virus.

S M Lemon1, R W Jansen, E A Brown.   

Abstract

Recent studies have documented a considerable degree of genetic divergence among wild-type hepatitis A virus (HAV) strains recovered from different geographical locations. Human HAV strains can be grouped into four genotypes (I, II, III and VII) and unique simian strains belong to three additional genotypes (IV, V and VI). Between each of these genotypes, the nucleotide sequence varies at 15-25% of base positions in the P1 region. Despite this, there is good evidence that most, if not all, human strains of HAV are closely related antigenically. In contrast, although simian strains recovered from Old World monkeys are cross-reactive in immunoassays employing polyclonal antibodies, these strains have significant antigenic differences from human HAV strains. Nonetheless, because biological differences in the host range of these strains apparently preclude significant human infection, this is unlikely to pose a problem in controlling HAV infections with active immunization. Inactivated and attenuated vaccines produced from genotype I human strains (HM175 or CR326) are likely to provide protection against all relevant human HAV strains.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1335657     DOI: 10.1016/0264-410x(92)90540-z

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  16 in total

Review 1.  Diagnosis of hepatitis a virus infection: a molecular approach.

Authors:  Omana V Nainan; Guoliang Xia; Gilberto Vaughan; Harold S Margolis
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

Review 2.  Clinical development of a new inactivated hepatitis A vaccine.

Authors:  E Vidor; B Fritzell; S Plotkin
Journal:  Infection       Date:  1996 Nov-Dec       Impact factor: 3.553

3.  Epidemiology and genetic characterization of hepatitis A virus genotype IIA.

Authors:  Delphine Desbois; Elisabeth Couturier; Vincent Mackiewicz; Arielle Graube; Marie-José Letort; Elisabeth Dussaix; Anne-Marie Roque-Afonso
Journal:  J Clin Microbiol       Date:  2010-06-30       Impact factor: 5.948

4.  Hepatitis a and e infection in international travellers.

Authors:  Joseph Torresi; Douglas Johnson
Journal:  Curr Infect Dis Rep       Date:  2011-06       Impact factor: 3.725

Review 5.  Hepatitis A: old and new.

Authors:  J A Cuthbert
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

6.  Recombination and selection in the evolution of picornaviruses and other Mammalian positive-stranded RNA viruses.

Authors:  Peter Simmonds
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

7.  Direct sequencing of hepatitis A virus strains isolated during an epidemic in France.

Authors:  V Apaire-Marchais; B H Robertson; V Aubineau-Ferre; M G Le Roux; F Leveque; L Schwartzbrod; S Billaudel
Journal:  Appl Environ Microbiol       Date:  1995-11       Impact factor: 4.792

8.  Clinical Features and Transmission Pattern of Hepatitis A: An Experience from a Hepatitis A Outbreak Caused by Two Cocirculating Genotypes in Sri Lanka.

Authors:  Niroshana J Dahanayaka; Tomoko Kiyohara; Suneth B Agampodi; Pradeep K Samaraweera; Gayani K Kulasooriya; Jagath C Ranasinghe; Saveen N Semage; Sayaka Yoshizaki; Takaji Wakita; Koji Ishii
Journal:  Am J Trop Med Hyg       Date:  2016-07-05       Impact factor: 2.345

9.  Molecular characterization of hepatitis A virus isolated from acute gastroenteritis patients in the Seoul region of Korea.

Authors:  S-H Park; E-J Kim; J-H Lee; S-S Choi; M-S Kim; S-S Jung; G-Y Han; H-S Yun; D-S Chun; S-S Oh; H-S Kim
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-05-26       Impact factor: 3.267

10.  Analysis of 5' nontranslated region of hepatitis A viral RNA genotype I from South Korea: comparison with disease severities.

Authors:  Tatsuo Kanda; Sook-Hyang Jeong; Fumio Imazeki; Keiichi Fujiwara; Osamu Yokosuka
Journal:  PLoS One       Date:  2010-12-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.